Cargando…
Quercetin Attenuates Cardiac Hypertrophy by Inhibiting Mitochondrial Dysfunction Through SIRT3/PARP-1 Pathway
Cardiac hypertrophy is an important characteristic in the development of hypertensive heart disease. Mitochondrial dysfunction plays an important role in the pathology of cardiac hypertrophy. Recent studies have shown that sirtuin 3 (SIRT3)/poly (ADP-ribose) polymerase-1 (PARP-1) pathway modulation...
Autores principales: | Chen, Wen-Jing, Cheng, Yan, Li, Wen, Dong, Xiao-Kang, Wei, Jian-liang, Yang, Chuan-Hua, Jiang, Yue-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581039/ https://www.ncbi.nlm.nih.gov/pubmed/34776960 http://dx.doi.org/10.3389/fphar.2021.739615 |
Ejemplares similares
-
SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity
por: Feng, Xiaojun, et al.
Publicado: (2020) -
Selective Inhibition of the Immunoproteasome β5i Prevents PTEN Degradation and Attenuates Cardiac Hypertrophy
por: Xie, Xin, et al.
Publicado: (2020) -
Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020) -
Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022) -
Quercetin Attenuates Atherosclerosis via Modulating Oxidized LDL-Induced Endothelial Cellular Senescence
por: Jiang, Yue-Hua, et al.
Publicado: (2020)